Debate: Transplant Is Still Necessary in the Era of Targeted Cellular Therapy for Acute Lymphoblastic Leukemia.

Clinical Lymphoma, Myeloma & Leukemia
Sajad Khazal, Partow Kebriaei

Abstract

Despite high complete remission (CR) rates, relapse remains a significant problem among subsets of patients with B acute lymphoblastic leukemia (ALL), and is associated with poor prognosis. The recent Food and Drug Administration approval of highly effective immunotherapies for B-lineage ALL (B-ALL), blinatumomab, inotuzumab ozogamicin, and tisagenlecleucel, a chimeric antigen receptor (CAR) modified T-cell therapy, targeting CD19, or CD22, have dramatically changed the therapeutic landscape for the treatment of B-ALL, resulting in high rates of deep and durable remissions. Therefore, there is now debate regarding the role of allogeneic hematopoietic cell transplantation (HCT) in this new landscape. Herein, we review these novel agents, and discuss the sequence of therapy, including allogeneic HCT in B-ALL.

References

Aug 2, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Denise M OlianskyTheresa Hahn
Feb 21, 2014·Science Translational Medicine·Marco L DavilaRenier Brentjens
Oct 16, 2014·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Apr 26, 2016·The Journal of Clinical Investigation·Cameron J TurtleDavid G Maloney
Jun 14, 2016·The New England Journal of Medicine·Hagop M KantarjianAnjali S Advani
Oct 27, 2016·Experimental Hematology·Xiaoou Zhou, Malcolm K Brenner
Aug 3, 2016·The Journal of Clinical Investigation·Partow KebriaeiLaurence J N Cooper
Dec 7, 2016·Blood·Nitin JainMarina Konopleva
Dec 22, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arend von StackelbergLia Gore
Jan 27, 2017·Science Translational Medicine·Waseem QasimPaul Veys
Mar 2, 2017·The New England Journal of Medicine·Hagop KantarjianMax S Topp
Sep 20, 2017·Nature Reviews. Clinical Oncology·Sattva S NeelapuElizabeth J Shpall
Feb 1, 2018·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Feb 1, 2018·The New England Journal of Medicine·Jae H ParkMichel Sadelain
Dec 29, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel W LeeSattva S Neelapu
Aug 23, 2019·Bone Marrow Transplantation·Elad Jacoby
Jan 9, 2020·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Apr 15, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nirali N ShahTerry J Fry

❮ Previous
Next ❯

Related Concepts